TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Senate Appropriations Committee Earmarks $118 Million for Centers, Orders Full Grant Funding October 9, 1987
TCL Archive HHS Agency Says It Has No Jurisdiction And No Cause to Act on I-ELCAP Allegations March 2, 2012